Determinants of Preterm Birth in Boston Birth Cohort
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03228875|
Recruitment Status : Recruiting
First Posted : July 25, 2017
Last Update Posted : July 25, 2017
|Condition or disease|
|Preterm Birth Birthweight Pregnancy Complications|
Any woman admitted to the Labor and Delivery floor at the Boston Medical Center (BMC) who delivers a singleton live infant and meets our case (gestational age <37 weeks or birthweight <2,500 grams) or control (full term birth with birthweight >2,500 grams) criteria will be eligible.
The Boston Birth Cohort has high-quality biospecimen collection, and comprehensive epidemiological, clinical, and environmental exposure data via standardized questionnaire interview and review of the electronic medical records.
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||12000 participants|
|Target Follow-Up Duration:||21 Years|
|Official Title:||Molecular Epidemiology of Preterm Birth: Environmental and Genetic Interactions Repository|
|Actual Study Start Date :||October 1998|
|Estimated Primary Completion Date :||December 2022|
|Estimated Study Completion Date :||December 2022|
- preterm birth [ Time Frame: at birth ]preterm birth is defined as gestational age less than 37 weeks
- birthweight [ Time Frame: at birth ]low birthweight is particularly focused on.
- pregnancy complications [ Time Frame: at delivery ]multiple pregnancy complications are examined including gestational diabetes, hypertensive disorders during pregnancy
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03228875
|Contact: Colleen Pearson, BAemail@example.com|
|United States, Massachusetts|
|Boston Medical Center||Recruiting|
|Boston, Massachusetts, United States, 02118|
|Contact: Barry Zuckerman, MD 617-414-5133 firstname.lastname@example.org|
|Principal Investigator:||Xiaobin Wang, MD, ScD||Johns Hopkins Bloomberg School of Public Health|